Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10032906HBVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS10040510HBVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS10042489HBVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30001392HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30001393HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30001394HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30013875HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30088317HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30019456HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30019457HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TCGA Plot Options
Drug Information
GeneJAK1
DrugBank IDDB14845
Drug NameFilgotinib
Target IDBE0004145
UniProt IDP23458
Regulation Typeinhibitor
PubMed IDs31912462
CitationsTarrant JM, Galien R, Li W, Goyal L, Pan Y, Hawtin R, Zhang W, Van der Aa A, Taylor PC: Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials. Rheumatol Ther. 2020 Mar;7(1):173-190. doi: 10.1007/s40744-019-00192-5. Epub 2020 Jan 7.
GroupsApproved; Investigational
Direct Classification
SMILESO=C(NC1=NN2C(C=CC=C2C2=CC=C(CN3CCS(=O)(=O)CC3)C=C2)=N1)C1CC1
Pathways
PharmGKB
ChEMBLCHEMBL3301607